Initial experience of the BREAST-Q breast-conserving therapy module

被引:61
|
作者
O'Connell, Rachel L. [1 ]
DiMicco, Rosa [1 ]
Khabra, Komel [2 ]
O'Flynn, Elizabeth A. [3 ]
deSouza, Nandita [3 ]
Roche, Nicola [1 ]
Barry, Peter A. [1 ]
Kirby, Anna M. [4 ]
Rusby, Jennifer E. [1 ]
机构
[1] Royal Marsden Hosp, Dept Breast Surg, Royal Marsden NHS Fdn Trust, Orchard House,Downs Rd, Sutton SM2 5PT, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Dept Stat, Sutton, Surrey, England
[3] Inst Canc Res & Royal Marsden NHS Fdn Trust, Canc Res UK, Canc Imaging Ctr, Sutton, Surrey, England
[4] Royal Marsden NHS Fdn Trust, Dept Clin Oncol, Sutton, Surrey, England
关键词
Breast cancer; Patient-reported outcome measures; BREAST-Q; Breast-conserving therapy; QUALITY-OF-LIFE; VALIDATED SURVEY INSTRUMENT; NO BOOST TRIAL; STAGE-I; CONSERVATIVE SURGERY; CANCER-TREATMENT; EORTC BOOST; FOLLOW-UP; PATIENT; RECONSTRUCTION;
D O I
10.1007/s10549-016-3966-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The most recently developed module of the BREAST-Q, a validated patient outcome measure, is for patients who have undergone breast-conserving therapy (BCT) for cancer. This aim of this study was to assess patient satisfaction and quality of life after BCT using BREAST-Q, investigate clinical risk factors for lower satisfaction and explore the relationship between patient satisfaction with the appearance of their breasts and the other domains of the BREAST-Q. Women who had undergone unilateral BCT in the preceding 1-6 years were invited to participate at the time of their annual surveillance mammogram. Clinicopathological data were collected from an electronic database. Linear regression was used to evaluate risk factors for lower satisfaction. Spearman's rho correlation coefficients were calculated to evaluate the relationship between domains. 200 women completed the questionnaire. Mean age was 60 years (SD 11.1). Time from surgery was 35.5 months (SD 17.8). Median score for 'Satisfaction with breasts' was 68 (interquartile range 55-80). Lowest scores were for 'sexual wellbeing' (57, IQR 45-66). On multivariate analysis, BMI at the time of surgery (p = 0.002), delayed wound healing (p = 0.001) and axillary surgery (p = 0.003) were independent risk factors for lower satisfaction. There was significant correlation between 'Satisfaction with breasts' and all other BREAST-Q domains. High BMI, delayed wound healing and axillary surgery are risk factors for lower patient satisfaction. This first publication reporting the whole dataset for the BREAST-Q BCT will serve as a benchmark for future studies of patient satisfaction following BCT.
引用
收藏
页码:79 / 89
页数:11
相关论文
共 50 条
  • [1] Initial experience of the BREAST-Q breast-conserving therapy module
    Rachel L. O’Connell
    Rosa DiMicco
    Komel Khabra
    Elizabeth A. O’Flynn
    Nandita deSouza
    Nicola Roche
    Peter A. Barry
    Anna M. Kirby
    Jennifer E. Rusby
    Breast Cancer Research and Treatment, 2016, 160 : 79 - 89
  • [2] Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module
    Stolpner, Ilona
    Heil, Joerg
    Feisst, Manuel
    Karsten, Maria Margarete
    Weber, Walter P.
    Blohmer, Jens-Uwe
    Forster, Tobias
    Golatta, Michael
    Schuetz, Florian
    Sohn, Christof
    Hennigs, Andre
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2759 - 2767
  • [3] Development and Validation of the BREAST-Q Breast-Conserving Therapy Module
    Klassen, Anne F.
    Dominici, Laura
    Fuzesi, Sarah
    Cano, Stefan J.
    Atisha, Dunya
    Locklear, Tracie
    Gregorowitsch, Madelijn L.
    Tsangaris, Elena
    Morrow, Monica
    King, Tari
    Pusic, Andrea L.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2238 - 2247
  • [4] Development and Validation of the BREAST-Q Breast-Conserving Therapy Module
    Anne F. Klassen
    Laura Dominici
    Sarah Fuzesi
    Stefan J. Cano
    Dunya Atisha
    Tracie Locklear
    Madelijn L. Gregorowitsch
    Elena Tsangaris
    Monica Morrow
    Tari King
    Andrea L. Pusic
    Annals of Surgical Oncology, 2020, 27 : 2238 - 2247
  • [5] Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module
    Ilona Stolpner
    Jörg Heil
    Manuel Feißt
    Maria Margarete Karsten
    Walter P. Weber
    Jens-Uwe Blohmer
    Tobias Forster
    Michael Golatta
    Florian Schütz
    Christof Sohn
    André Hennigs
    Annals of Surgical Oncology, 2019, 26 : 2759 - 2767
  • [6] Comments on the Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module
    Fernando Hernanz
    Jaime Jimeno
    Lucia Paz
    Pedro Muñoz
    Annals of Surgical Oncology, 2019, 26 : 855 - 856
  • [7] Comments on the Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module
    Hernanz, Fernando
    Jimeno, Jaime
    Paz, Lucia
    Munoz, Pedro
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S855 - S856
  • [8] Development of a new BREAST-Q module for Breast Cancer Patients: The Breast-Conserving Therapy (BCT) Module
    Scott, Amie M.
    McCarthy, Colleen M.
    Klassen, Anne F.
    Cano, Stefan J.
    Pusic, Andrea L.
    Jhanwar, Sabrina M.
    Morrow, Monica
    QUALITY OF LIFE RESEARCH, 2010, 19 : 112 - 113
  • [9] BREAST-Q Breast-Conserving Therapy Module: Normative Data from a Dutch Sample of 9059 Women
    Oemrawsingh, Arvind
    Clarijs, Marloes E.
    Pusic, Andrea L.
    Lingsma, Hester F.
    Verhoef, Cornelis
    Hazelzet, Jan A.
    Koppert, Linetta B.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 150 (05) : 985 - 993
  • [10] Response to: Comments on the Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module, by Hernanz et al.
    Stolpner, Ilona
    Hennigs, Andre
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S857 - S858